These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 9135700
1. Demonstration of thyroid stimulating activity within H chain fragments of TSAb-IgG by protease digestion and reduction. Kouki T, Inui T, Hachiya T, Okabe H, Ochi Y, Kajita Y. Clin Endocrinol (Oxf); 1997 Feb; 46(2):183-8. PubMed ID: 9135700 [Abstract] [Full Text] [Related]
2. Demonstration of thyroactive smaller components released from TSAb-IgG by protease digestion. Ogura M, Kouki T, Inui T, Hachiya T, Ochi Y, Kajita Y. Thyroid; 1995 Dec; 5(6):449-54. PubMed ID: 8808094 [Abstract] [Full Text] [Related]
3. Demonstration of fragments with thyroid stimulating activity from thyroid stimulation blocking antibodies-IgG molecules by papain digestion. Kouki T, Inul T, Yamashiro K, Hachiya T, Ochi Y, Kajita Y, Takasu N, Sato Y, Nagata A. Clin Endocrinol (Oxf); 1997 Dec; 47(6):693-8. PubMed ID: 9497876 [Abstract] [Full Text] [Related]
4. Polyethylene glycol augments thyroid cAMP responses by fragments from protease-digested TSAb or TSBAb-IgG. Yamashiro K, Takasu N, Inui T, Kouki T, Ochi Y, Kajita Y, Sato Y, Nagata A. Life Sci; 1999 Dec; 64(13):1109-16. PubMed ID: 10210273 [Abstract] [Full Text] [Related]
7. Immunological similarity of thyroid stimulating antibody (TSAb) and thyroid blocking antibody (TBAb) with animal IgG. Ochi Y, Kajita Y, Hachiya T, Hamaoki M. Endocr J; 2012 Dec; 59(1):73-9. PubMed ID: 22082835 [Abstract] [Full Text] [Related]
8. Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity. Zakarija M. J Clin Lab Immunol; 1983 Feb; 10(2):77-85. PubMed ID: 6133001 [Abstract] [Full Text] [Related]
9. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb. Ochi Y, Kajita Y, Hachiya T, Hamaoki M. Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575 [Abstract] [Full Text] [Related]
12. The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity. Zakarija M. Horm Res; 1980 Jun; 13(1):1-15. PubMed ID: 6777285 [Abstract] [Full Text] [Related]
13. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay. Inui T, Kouki T, Yamashiro K, Hachiya T, Ochi Y, Kajita Y, Sato Y, Nagata A. Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497 [Abstract] [Full Text] [Related]
14. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T. Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [Abstract] [Full Text] [Related]
19. The mechanism involved in the conversion of thyrotropin receptor-bound blocking-type immunoglobulin G (IgG) to the stimulating-type by anti-human IgG antibodies. Taniguchi S, Yoshida A, Shigemasa C, Mitani Y, Ueta Y, Urabe K, Mashiba H. Endocrinology; 1990 Feb; 126(2):796-803. PubMed ID: 2153526 [Abstract] [Full Text] [Related]